Obesity Epidemic and New GLP-1Drugs (Ozempic/Mounjaro).

The Best of 702 Weekend Breakfast - A podcast by 702 - Sundays

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Society & Culture

Chief Clinical Officer at Discovery Health, Dr Noluthando Nematswerani on the effects of non-diabetic consumers abusing diabetes medicine like GLP-1Drugs (Ozempic/Mounjaro) for weight loss purposes. This after reports of supply shortages and ration how many injection pens filled with human insulin, for the treatment of diabetes.See omnystudio.com/listener for privacy information.

Visit the podcast's native language site